Blockade of NKG2D synergized with CTLA4-Ig in promoting long-term graft survival in murine models of cardiac transplantation

Transplantation

Volumn 93, Issue 4, 2012, Pages 356-363

  Li, Jun ^a   Zhu, Hongfei ^b   Wang, Sihua ^a   Ye, Ping ^a   Liu, Chenggui ^a   Wu, Jie ^a   Xia, Jiahong ^a,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY   (China)

^c NONE   (China)

Author keywords

Cardiac transplantation; IL 17; NKG2D; T Cell

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; H60 ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 17; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS 1 RELATED GENE B PROTEIN; MINOR HISTOCOMPATIBILITY ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2D; RETINOIC ACID EARLY INDUCIBLE 1 PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART MUSCLE CONTRACTILITY; HEART TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOREGULATION; IN VIVO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME;

EID: 84857042196     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31823ffce7     Document Type: Article

References (49)

1. Weis M, von Scheidt W. Cardiac allograft vasculopathy: A review. Circulation 1997; 96: 2069.
2. Pearson TC, Alexander DZ, Winn KJ, et al. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57: 1701.
3. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
4. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992; 89: 11102.
5. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
6. Rincon-Orozco B, Kunzmann V, Wrobel P, et al. Activation of V gamma 9V delta 2 T cells by NKG2D. J Immunol 2005; 175: 2144.
7. Lopez-Larrea C, Suarez-Alvarez B, Lopez-Soto A, et al. The NKG2D receptor: Sensing stressed cells. Trends Mol Med 2008; 14: 179.
8. Zou Y, Stastny P, Susal C, et al. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007; 357: 1293.
9. Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 2004; 5: 996.
10. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003; 3: 781.
11. Kim J, Chang CK, Hayden T, et al. The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection. J Immunol 2007; 179: 6416.
12. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: An immunologic functional perspective. Annu Rev Immunol 2009; 27: 451.
13. Zwirner NW, Marcos CY, Mirbaha F, et al. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol 2000; 61: 917.
14. Zou Y, Mirbaha F, Lazaro A, et al. MICA is a target for complementdependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies. Hum Immunol 2002; 63: 30.
15. Suarez-Alvarez B, Lopez-Vazquez A, et al. The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection. Am J Transplant 2007; 7: 1842.
16. Cerwenka A, Bakker AB, McClanahan T, et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000; 12: 721.
17. Feng L, Cheng F, Ye Z, et al. The effect of renal ischemia-reperfusion injury on expression of RAE-1 and H60 in mice kidney. Transplant Proc 2006; 38: 2195.
18. Zhang ZX, Wang S, Huang X, et al.NKcells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J Immunol 2008; 181: 7489.
19. Pende D, Cantoni C, Rivera P, et al. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol 2001; 31: 1076.
20. Van der Touw W, Bromberg JS. Natural killer cells and the immune response in solid organ transplantation. Am J Transplant 2010; 10: 1354.
21. Schnickel GT, Bastani S, Hsieh GR, et al. Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection. J Immunol 2008; 180: 4714.
22. Fischbein MP, Ardehali A, Yun J, et al. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants. J Immunol 2000; 165: 7316.
23. Suarez-Alvarez B, Lopez-Vazquez A, Baltar JM, et al. Potential role of NKG2Dand its ligands in organ transplantation: New target for immunointervention. Am J Transplant 2009; 9: 251.
24. Saiura A, Mataki C, Murakami T, et al. A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis. Transplantation 2001; 72: 320.
25. Nagano H, Mitchell RN, Taylor MK, et al. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 1997; 100: 550.
26. Tellides G, Tereb DA, Kirkiles-Smith NC, et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000; 403: 207.
27. Fernandez NC, Lozier A, Flament C, et al. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999; 5: 405.
28. Delfs MW, Furukawa Y, Mitchell RN, et al. CD8+ T cell subsets TC1 and TC2 cause different histopathologic forms of murine cardiac allograft rejection. Transplantation 2001; 71: 606.
29. Ferrick DA, Schrenzel MD, Mulvania T, et al. Differential production of interferon-gamma and interleukin-4 in response to Th1-and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature 1995; 373: 255.
30. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004; 4: 583.
31. Bouhlel MA, Derudas B, Rigamonti E, et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with antiinflammatory properties. Cell Metab 2007; 6: 137.
32. Li J, Chen G, Ye P, et al. CCR5 blockade in combination with cyclosporine increased cardiac graft survival and generated alternatively activated macrophages in primates. J Immunol 2011; 186: 3753.
33. Tzachanis D, Berezovskaya A, Nadler LM, et al. Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses. Blood 2002; 99: 1465.
34. Geldhof AB, Van Ginderachter JA, Liu Y, et al. Antagonistic effect of NK cells on alternatively activated monocytes: A contribution of NK cells to CTL generation. Blood 2002; 100: 4049.
35. Burrell BE, Csencsits K, Lu G, et al. CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol 2008; 181: 3906.
36. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, et al. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 2008; 205: 3133.
37. Dong C. Diversification of T-helper-cell lineages: Finding the family root of IL-17-producing cells. Nat Rev Immunol 2006; 6: 329.
38. Tajima M, Wakita D, Noguchi D, et al. IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells. J Exp Med 2008; 205: 1019.
39. Itoh S, Nakae S, Axtell RC, et al. IL-17 contributes to the development of chronic rejection in a murine heart transplant model. J Clin Immunol 2010; 30: 235.
40. Ogasawara K, Hamerman JA, Ehrlich LR, et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004; 20: 757.
41. Ito Y, Kanai T, Totsuka T, et al. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.AmJ Physiol Gastrointest Liver Physiol 2008; 294: G199.
42. Kjellev S, Haase C, Lundsgaard D, et al. Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice. Eur J Immunol 2007; 37: 1397.
43. Dehmel S, Wang S, Schmidt C, et al. Chemokine receptor Ccr5 deficiency induces alternative macrophage activation and improves longterm renal allograft outcome. Eur J Immunol 2010; 40: 267.
44. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343.
45. Lin W, Harding HP, Ron D, et al. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma. J Cell Biol 2005; 169: 603.
46. Mahalingam S, Karupiah G, Takeda K, et al. Enhanced resistance in STAT6-deficient mice to infection with ectromelia virus. Proc Natl Acad Sci USA 2001; 98: 6812.
47. Nagata T, McKinley L, Peschon JJ, et al. Requirement of IL-17RA in ConAinduced hepatitis and negative regulation of IL-17 production in mouse T cells. J Immunol 2008; 181: 7473.
48. Gorbacheva V, Fan R, Li X, et al. Interleukin-17 promotes early allograft inflammation. Am J Pathol 2010; 177: 1265.
49. Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001; 108: 430.